INS and metabolic syndrome: Further, the CpG site cg18181703 (SOCS3) identified in our study, has been associated with metabolic syndrome (MetS) traits such as central obesity, fat depots, insulin responsiveness, and plasma lipids65, as well as type 2 diabetes incidence66.